GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dare Bioscience Inc (NAS:DARE) » Definitions » Shiller PE Ratio

Dare Bioscience (Dare Bioscience) Shiller PE Ratio : (As of Jun. 04, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Dare Bioscience Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Dare Bioscience Shiller PE Ratio Historical Data

The historical data trend for Dare Bioscience's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dare Bioscience Shiller PE Ratio Chart

Dare Bioscience Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dare Bioscience Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Dare Bioscience's Shiller PE Ratio

For the Biotechnology subindustry, Dare Bioscience's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dare Bioscience's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dare Bioscience's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dare Bioscience's Shiller PE Ratio falls into.



Dare Bioscience Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dare Bioscience's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Dare Bioscience's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.07/131.7762*131.7762
=-0.070

Current CPI (Mar. 2024) = 131.7762.

Dare Bioscience Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -4.400 100.560 -5.766
201409 -2.800 100.428 -3.674
201412 -3.400 99.070 -4.522
201503 -4.100 99.621 -5.423
201506 -3.700 100.684 -4.843
201509 -3.900 100.392 -5.119
201512 -3.900 99.792 -5.150
201603 -4.900 100.470 -6.427
201606 -3.970 101.688 -5.145
201609 -0.020 101.861 -0.026
201612 -0.230 101.863 -0.298
201703 -0.270 102.862 -0.346
201706 -0.550 103.349 -0.701
201709 -0.330 104.136 -0.418
201712 -1.510 104.011 -1.913
201803 -0.880 105.290 -1.101
201806 -0.320 106.317 -0.397
201809 -0.230 106.507 -0.285
201812 -0.250 105.998 -0.311
201903 -0.270 107.251 -0.332
201906 -0.290 108.070 -0.354
201909 -0.200 108.329 -0.243
201912 -0.210 108.420 -0.255
202003 -0.180 108.902 -0.218
202006 -0.270 108.767 -0.327
202009 -0.240 109.815 -0.288
202012 -0.220 109.897 -0.264
202103 -0.160 111.754 -0.189
202106 -0.180 114.631 -0.207
202109 -0.180 115.734 -0.205
202112 -0.180 117.630 -0.202
202203 -0.100 121.301 -0.109
202206 0.005 125.017 0.005
202209 -0.080 125.227 -0.084
202212 -0.190 125.222 -0.200
202303 -0.090 127.348 -0.093
202306 -0.100 128.729 -0.102
202309 -0.090 129.860 -0.091
202312 -0.060 129.419 -0.061
202403 -0.070 131.776 -0.070

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dare Bioscience  (NAS:DARE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Dare Bioscience Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Dare Bioscience's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dare Bioscience (Dare Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Executives
Sophia Nnenna Ononye-onyia director 1270 AVE OF THE AMERICAS, 7TH FL - 1026, NEW YORK NY 10020
Sabrina Martucci Johnson director, officer: Chef Executive Officer 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
John A Fair officer: Chief Strategy Officer C/O DARE BIOSCIENCE, INC., 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Cheryl R Blanchard director C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Roger Hawley director 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO CA 92122
Gregory W Matz director 1 WHITE OAK WAY, NOVATO CA 94949
Jessica D. Grossman director C/O DARE BIOSCIENCE, INC., 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Lisa Walters-hoffert officer: Chief Financial Officer C/O DARE BIOSCIENCE, INC., 10210 CAMPUS POINT DRIVE, SUITE 150, SAN DIEGO CA 92121
Robin Joan Steele director 3280 BAYSHORE BOULEVARD, BRISBANE CA 94005
Scott Eliasof officer: SVP, Chief Scientific Officer C/O CERULEAN PHARMA INC., 35 GATEHOUSE DRIVE, WALTHAM MA 02451
David R Walt director 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Adrian Senderowicz officer: SVP, Chief Medical Officer C/O PUMA BIOTECHNOLOGY, INC., 10880 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES CA 90024
Stuart A Arbuckle director VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY ST., CAMBRIDGE MA 02139
Alejandra Carvajal officer: VP, General Counsel C/O CERULEAN PHARMA INC., 840 MEMORIAL DRIVE, 5TH FLOOR, CAMBRIDGE MA 02139
James E Oneill officer: Principal Accounting Officer 15 GREENBRIAR CIRCLE, ANDOVER MA 01810

Dare Bioscience (Dare Bioscience) Headlines

From GuruFocus